These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 368005)

  • 21. [Antibacterial activity of tobramycin on Pseudomonas aeruginosa].
    Fleurette J; Flandrois JP
    Nouv Presse Med; 1974 Apr; 3(0):40-2. PubMed ID: 4209337
    [No Abstract]   [Full Text] [Related]  

  • 22. Serratia marcescens: biochemical characteristics, antimicrobial sensitivity and clinical significance.
    Puthucheary SD; Ngeow YF
    Malays J Pathol; 1981 Aug; 4():35-41. PubMed ID: 6764658
    [No Abstract]   [Full Text] [Related]  

  • 23. Sensitivity of hospital strains of Serratia marcescens to aminoglycosides.
    Vandepitte JM; Verbist L; Meeussen L
    Acta Clin Belg; 1976; 31(3):153-7. PubMed ID: 782126
    [No Abstract]   [Full Text] [Related]  

  • 24. Aminoglycoside resistance patterns of Serratia marcescens strains of clinical origin.
    Coria-Jiménez R; Ortiz-Torres C
    Epidemiol Infect; 1994 Feb; 112(1):125-31. PubMed ID: 8119351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial susceptibility of clinical isolates of Serratia marcescens.
    Alvarez JS; Regueiro B; Garrido MJ
    Antimicrob Agents Chemother; 1979 Oct; 16(4):523-4. PubMed ID: 391150
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The in vivo and in vitro potentiation of sulfamethoxazole by trimethoprim against strains of Serratia marcescens.
    Grunberg E; Beskid G; DeLorenzo WF; Cleeland R
    Int J Clin Pharmacol; 1973 Aug; 8(1):47-50. PubMed ID: 4580383
    [No Abstract]   [Full Text] [Related]  

  • 27. Serratia marcescens: a study of the sensitivity of British isolates to antibacterial agents and their combinations.
    Gray J; McGhie D; Ball AP
    J Antimicrob Chemother; 1978 Nov; 4(6):551-9. PubMed ID: 361679
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hospital infection due to Serratia marcescens and its sensitivity to antibiotics].
    Filloy L; Serrano D; Borjas E
    Bol Med Hosp Infant Mex; 1980; 37(5):871-7. PubMed ID: 7000092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of carbenicillin - aminoglycoside and of cephalothin-aminoglycoside combinations against enterococci in vitro.
    Klastersky J; Daneau D
    Pathol Biol (Paris); 1975 May; 23(5):345-8. PubMed ID: 1105331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro synergistic effects of fisetin and norfloxacin against aquatic isolates of Serratia marcescens.
    Dong J; Ruan J; Xu N; Yang Y; Ai X
    FEMS Microbiol Lett; 2016 Jan; 363(1):fnv220. PubMed ID: 26567906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bacteriophage typing of clinically isolated Serratia marcescens.
    Hamilton RL; Brown WJ
    Appl Microbiol; 1972 Dec; 24(6):899-906. PubMed ID: 4568252
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Drug resistance of bacteria--the current status and future prospect. 4. Serratia].
    Kimura S
    Nihon Rinsho; 1984 Mar; 42(3):671-5. PubMed ID: 6381804
    [No Abstract]   [Full Text] [Related]  

  • 33. [Genes of resistance to aminoglycoside antibiotics in clinical strains of Serratia marcescens and the enzyme encoded by them].
    Kolganov AN; Vakulenko SB
    Antibiot Khimioter; 1992 Nov; 37(11):10-4. PubMed ID: 1300924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outer membrane protein alterations in Serratia marcescens resistant against aminoglycoside and beta-lactam antibiotics.
    Traub WH; Bauer D
    Chemotherapy; 1987; 33(3):172-6. PubMed ID: 3297527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of carbenicillin, ticarcillin, aminoglycosides and combinations against Staphylococcus aureus.
    Watanakunakorn C; Glotzbecker C
    J Antimicrob Chemother; 1979 Mar; 5(2):151-8. PubMed ID: 429247
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical and laboratory studies with tobramycin.
    Geddes AM; Goodall JA; Speirs CF; Gillett AP; Andrews J; Williams JD
    Chemotherapy; 1974; 20(4):245-56. PubMed ID: 4212996
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of the in vitro activity of new beta-lactams and aminoglycosides against clinical isolates of Pseudomonas aeruginosa.
    Patzer J; Gieburowska R; Dzierzanowska D
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Oct; 253(1):110-20. PubMed ID: 6817544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mecillinam--an amidino penicillin which acts synergistically with other beta-lactam compounds.
    Neu HC
    J Antimicrob Chemother; 1977 Jul; 3 Suppl B():43-52. PubMed ID: 893247
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparative study of the antibacterial activity of aminoglycoside antibiotics and their combinations with carbenicillin against Pseudomonas aeruginosa].
    Iakushkina IV; Shapovalova SP; Malkova IV
    Antibiotiki; 1982 Aug; 27(8):601-7. PubMed ID: 6812489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outbreak of Serratia marcescens Coproducing ArmA and CTX-M-15 Mediated High Levels of Resistance to Aminoglycoside and Extended-Spectrum Beta-Lactamases, Algeria.
    Batah R; Loucif L; Olaitan AO; Boutefnouchet N; Allag H; Rolain JM
    Microb Drug Resist; 2015 Aug; 21(4):470-6. PubMed ID: 25884511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.